Skip to main content
Adam Stone

Adam Stone

Chief Investment Officer & Head of Research, Perceptive Advisors
In 2006 Adam Stone joined Perceptive. Prior to Perceptive he was a senior analyst at Ursus Capital. During his five years there he focused on biotech and specialty pharmaceuticals. He graduated, with honors, from Princeton University with a B.A. in molecular biology. Adam serves on the board of directors for several of Perceptive’s portfolio companies, including Solid Biosciences, Renovia, and Xontogeny. Additionally, Adam serves as the CEO of ARYA Sciences Acquisition Corp, and he is a member of Perceptive’s internal investment committees for the credit opportunities and venture funds.

Double Helix


Supporting Bank Sponsor


Premier Sponsors

Conference Sponsors


Media Partner


Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.